Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazole.

Source:http://linkedlifedata.com/resource/pubmed/id/20025819

Download in:

View as

General Info

PMID
20025819